Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;113(8):1264-70.
doi: 10.1016/j.ophtha.2006.02.054.

Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21

Affiliations

Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21

Roy C Milton et al. Ophthalmology. 2006 Aug.

Abstract

Purpose: To evaluate the effect of the multivitamin Centrum on the development and progression of age-related lens opacities.

Design: Clinic-based prospective cohort study.

Participants: Four thousand five hundred ninety individuals with at least one natural lens and photographic follow-up (median, 6.3 years) were assessed for development or progression of lens opacities.

Main outcome measures: Progression of "any" lens opacity or type-specific opacity was ascertained from lens photographs taken at baseline and at annual visits beginning at year 2.

Methods: The Age-Related Eye Disease Study (AREDS) showed no statistically significant effect of a high-dose antioxidant formulation on progression of lens opacities. Centrum also was provided to approximately two thirds of the study participants. Because Centrum use was elective, a logistic regression model of baseline characteristics was used to generate a propensity score for Centrum use. Repeated-measures logistic regression, adjusted for propensity score and other covariates, was used to evaluate associations of Centrum use and lens opacity.

Results: Centrum use, adjusted for propensity score and other covariates, was associated with a reduction in "any" lens opacity progression (odds ratio [OR] = 0.84, 95% confidence interval [CI] = 0.72-0.98, P = 0.025). Results for individual lens opacity types suggested that Centrum use was protective for nuclear opacity events (OR = 0.75, 95% CI = 0.61-0.91, P = 0.004).

Conclusion: Observational data from the AREDS and other studies suggest that use of a multivitamin may delay the progression of lens opacities. A National Eye Institute-sponsored clinical trial scheduled for completion in 2007 will provide additional data on Centrum use and cataract development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Examples of lens opacity progression in Age-Related Eye Disease Study (AREDS) participants. Nuclear opacity graded from slit-lamp photographs (model SL-6E, Topcon Corp., Tokyo, Japan) increased from 2.0 U (equal to AREDS standard photograph 3) at baseline (A) to 3.9 U (approaching standard photograph 5) at the 5-year visit (B). Cortical opacity within 5 mm of the lens center graded from retroillumination photographs (Neitz Instruments Co., Ltd., Tokyo, Japan) increased from 6% at baseline (C) to 45% at the 6-year visit (D). Posterior subcapsular opacity within 5 mm of the lens center increased from 6% at baseline (E) to 22% at the 5-year visit (F). Reproduced with permission from Archives of Ophthalmology (2001;119:1444). Copyright © 2001, American Medical Association. All rights reserved.

References

    1. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health. 1994;84:788–92. - PMC - PubMed
    1. Leske MC, Chylack LT, Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the Longitudinal Study of Cataract. Ophthalmology. 1998;105:831–6. - PubMed
    1. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol. 2000;118:1556–63. - PubMed
    1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439–52. - PMC - PubMed
    1. Christen WG, Manson JE, Glynn RJ, et al. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol. 2003;121:372–8. - PubMed

Publication types